>>Signaling Pathways>> Cell Cycle/Checkpoint>> Inositol Phosphates>>D-myo-Inositol-1,4,6-triphosphate (sodium salt)

D-myo-Inositol-1,4,6-triphosphate (sodium salt) (Synonyms: Ins(1,4,6)P3, 1,4,6IP3)

Catalog No.GC43524

D-myo-Inositol-1,4,6-phosphate (Ins(1,4,6)-P3) is a member of the inositol phosphate (InsP) family that play critical roles as small, soluble second messengers in the transmission of cellular signals.

Products are for research use only. Not for human use. We do not sell to patients.

D-myo-Inositol-1,4,6-triphosphate (sodium salt) Chemical Structure

Cas No.: 157380-18-2

Size 가격 재고 수량
100μg
US$83.00
재고 있음
500μg
US$378.00
재고 있음
1mg
US$672.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

D-myo-Inositol-1,4,6-phosphate (Ins(1,4,6)-P3) is a member of the inositol phosphate (InsP) family that play critical roles as small, soluble second messengers in the transmission of cellular signals. The most studied InsP, Ins(1,4,5)-P3, is a second messenger produced in cells by phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol-4,5-biphosphate. Binding of Ins(1,4,5)-P3 to its receptor on the endoplasmic reticulum results in opening of the calcium channels and an increase in intracellular calcium. Ins(1,4,6)-P3 (tested as the meso compound) is 9-fold less potent than Ins(1,4,5)-P3 at initiating Ca2+ release when injected into Xenopus oocytes.

리뷰

Review for D-myo-Inositol-1,4,6-triphosphate (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-myo-Inositol-1,4,6-triphosphate (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.